New legislation needed for pharmacy data access say bodies
Pharmacies must continue to have the enhanced access to patient data that has been available to them during the Covid-19 pandemic, sector bodies have said.
In a December 7 letter to NHS England & Improvement, NHS Digital and NHSX, the Royal Pharmaceutical Society and Pharmaceutical Services Negotiating Committee say new legislation must be introduced to ensure ongoing access to summary care records with additional information (SCR with AI), as well as care record (LHCR) medicines-related information.
Pharmacies currently have access to this data under the Coronavirus Bill, but there are as yet no legal provisions to carry this forward once emergency legislation lapses.
The letter argues that LHCR access should be standard for pharmacists and pharmacy technicians to support patient care, and that IT LHCR compatibility standards should be introduced.
Claire Anderson, chair of the English pharmacy board, said: “It is important that we build a more digitally connected NHS and giving pharmacists continued access to the additional information in summary care records is a good place to start. People are becoming increasingly familiar with working digitally and there is growing opinion on sharing information to provide the best possible care for patients.
“We support the ongoing work to set common clinical standards, which allows crucial information to flow across the health system. Ensuring that community pharmacy is part of that system is critical in providing better patient care.”
PSNC director of NHS services Alistair Buxton said: “We need the NHS to do more to help us help patients. Pharmacy professionals should be able to easily access relevant patient information so they can support patients to make the most of their medicines and identify any possible concenrs, thereby reducing the likelihood of problems escalating.
“Access to this additional information during the pandemic has been crucial for pharmacy teams, and it would be a retrograde step of the amount of detail available to them reverts to its pre-pandemic level.”
Record my learning outcomes
Inspiring stories related to health, fitness and the pursuit of wellbeing
More like this
New antibody study will inform Govt lockdown strategy
A new Government-funded study is using Covid-19 antibody testing to determine how widespread coronavirus is in the community in Britain.
3 Min Article
NICE approves secukinumab for chronic pain condition
NICE has recommended the use of secukinumab as an option for treating a chronic back pain condition affecting young adults.
2 Min Article
Well pilots digital consultation service with GP practices
Well Pharmacy is launching a new pilot service whereby its pharmacists provide digital consultations for minor ailments on behalf of GP practices.
3 Min Article
Pharmacies still failing to meet safety standards, warns PDA
The PDA warns many UK pharmacies are still failing to meet key patient safety standards such as adequate staffing levels.
3 Min Article
Managing hay fever: help meet your customers' needs
This module will improve your hay fever knowledge, helping you to understand its impact on sufferers and recommend the right products to ease symptoms
15 Min Module
OTC Omeprazole tablets 20mg: an opportunity for pharmacy
This module highlights a new opportunity to treat heartburn and reflux in the pharmacy with Omeprazole 20mg, which is newly available for customers to purchase OTC.
22 Min Module